Decreases in Both the Seroprevalence of Serum Antibodies and Seroprotection against Japanese Encephalitis Virus among Vaccinated Children
- 25 March 2019
- journal article
- research article
- Published by Elsevier in Virologica Sinica
- Vol. 34 (3) , 243-252
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Estimated global incidence of Japanese encephalitis:Bulletin of the World Health Organization, 2011
- Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titersVaccine, 2011
- Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in ChinaVaccine, 2011
- Overview: Japanese encephalitisProgress in Neurobiology, 2010
- Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination programVaccine, 2010
- A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responsesVaccine, 2008
- Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2–3 September, 2004Vaccine, 2005
- Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townshipsAmerican Journal of Infection Control, 2003
- NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Japanese encephalitisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Japanese Encephalitis VaccinePediatrics International, 1988